Fibroblasts—a key host cell type in tumor initiation, progression, and metastasis

References

• Ostman A, Augsten M. Cancer-associated fibroblasts and tumor growth—bystanders turning into key players. Curr Opin Genet Dev. 2009;19:67–73.
   PubMed Web of Science ®Google Scholar
• Pietras K, Ostman A. Hallmarks of cancer: interactions with the tumor stroma. Exp Cell Res. 2010;316:1324–31.
   PubMed Web of Science ®Google Scholar
• McAllister SS, Weinberg RA. Tumor-host interactions: a far-reaching relationship. J Clin Oncol. 2010;28:4022–8.
   PubMed Web of Science ®Google Scholar
• Bergfeld SA, DeClerck YA. Bone marrow-derived mesenchymal stem cells and the tumor microenvironment. Cancer Metastasis Rev. 2010;29:249–61.
   PubMed Web of Science ®Google Scholar
• Korkaya H, Liu S, Wicha MS. Breast cancer stem cells, cytokine networks, and the tumor microenvironment. J Clin Invest. 2011;121:3804–9.
   PubMed Web of Science ®Google Scholar
• Calvo F, Sahai E. Cell communication networks in cancer invasion. Curr Opin Cell Biol. 2011;23:621–9.
   Google Scholar
• Erez N, Truitt M, Olson P, Arron ST, Hanahan D. Cancer-associated fibroblasts are activated in incipient neoplasia to orchestrate tumor-promoting inflammation in an NF-kappaB-dependent manner. Cancer Cell. 2010;17:135–47.
   PubMed Web of Science ®Google Scholar
• Lyons TR, O'Brien J, Borges VF, Conklin MW, Keely PJ, Eliceiri KW, Postpartum mammary gland involution drives progression of ductal carcinoma in situ through collagen and COX-2. Nat Med. 2011;17:1109–15.
   PubMed Web of Science ®Google Scholar
• Hu M, Yao J, Carroll DK, Weremowicz S, Chen H, Carrasco D, Regulation of in situ to invasive breast carcinoma transition. Cancer Cell. 2008;13:394–406.
   PubMed Web of Science ®Google Scholar
• Jedeszko C, Victor BC, Podgorski I, Sloane BF. Fibroblast hepatocyte growth factor promotes invasion of human mammary ductal carcinoma in situ. Cancer Res. 2009;69:9148–55.
   PubMed Web of Science ®Google Scholar
• Debnath J, Brugge JS. Modelling glandular epithelial cancers in three-dimensional cultures. Nat Rev Cancer. 2005;5:675–88.
   PubMed Web of Science ®Google Scholar
• Lee GY, Kenny PA, Lee EH, Bissell MJ. Three-dimensional culture models of normal and malignant breast epithelial cells. Nat Methods. 2007;4:359–65.
   PubMed Web of Science ®Google Scholar
• Jeffers M, Rong S, Vande Woude GF. Enhanced tumorigenicity and invasion-metastasis by hepatocyte growth factor/scatter factor-met signalling in human cells concomitant with induction of the urokinase proteolysis network. Mol Cell Biol. 1996;16:1115–25.
   PubMed Web of Science ®Google Scholar
• Pepper MS, Matsumoto K, Nakamura T, Orci L, Montesano R. Hepatocyte growth factor increases urokinase-type plasminogen activator (u-PA) and u-PA receptor expression in Madin-Darby canine kidney epithelial cells. J Biol Chem. 1992;267:20493–6.
   PubMed Web of Science ®Google Scholar
• Levental KR, Yu H, Kass L, Lakins JN, Egeblad M, Erler JT, Matrix crosslinking forces tumor progression by enhancing integrin signaling. Cell. 2009;139:891–906.
   PubMed Web of Science ®Google Scholar
• Goetz JG, Minguet S, Navarro-Lerida I, Lazcano JJ, Samaniego R, Calvo E, Biomechanical remodeling of the microenvironment by stromal caveolin-1 favors tumor invasion and metastasis. Cell. 2011;146:148–63.
   PubMed Web of Science ®Google Scholar
• Witkiewicz AK, Dasgupta A, Sotgia F, Mercier I, Pestell RG, Sabel M, An absence of stromal caveolin-1 expression predicts early tumor recurrence and poor clinical outcome in human breast cancers. Am J Pathol. 2009;174:2023–34.
   PubMed Web of Science ®Google Scholar
• Liu S, Ginestier C, Ou SJ, Clouthier SG, Patel SH, Monville F, Breast cancer stem cells are regulated by mesenchymal stem cells through cytokine networks. Cancer Res. 2011;71:614–24.
   PubMed Web of Science ®Google Scholar
• Medema JP, Vermeulen L. Microenvironmental regulation of stem cells in intestinal homeostasis and cancer. Nature. 2011;474:318–26.
   PubMed Web of Science ®Google Scholar
• Scheel C, Eaton EN, Li SH, Chaffer CL, Reinhardt F, Kah KJ, Paracrine and autocrine signals induce and maintain mesenchymal and stem cell states in the breast. Cell. 2011;145:926–40.
   PubMed Web of Science ®Google Scholar
• Brabletz T, Jung A, Reu S, Porzner M, Hlubek F, Kunz-Schughart LA, Variable beta-catenin expression in colorectal cancers indicates tumor progression driven by the tumor environment. Proc Natl Acad Sci USA. 2001;98:10356–61.
   PubMed Web of Science ®Google Scholar
• Vermeulen L, De Sousa EMF, van der Heijden M, Cameron K, de Jong JH, Borovski T, Wnt activity defines colon cancer stem cells and is regulated by the microenvironment. Nat Cell Biol. 2010;12:468–76.
   PubMed Web of Science ®Google Scholar
• Muller T, Bain G, Wang X, Papkoff J. Regulation of epithelial cell migration and tumor formation by beta-catenin signaling. Exp Cell Res. 2002;280:119–33.
   PubMed Web of Science ®Google Scholar
• Rasola A, Fassetta M, De Bacco F, D'Alessandro L, Gramaglia D, Di Renzo MF, A positive feedback loop between hepatocyte growth factor receptor and beta-catenin sustains colorectal cancer cell invasive growth. Oncogene. 2007;26:1078–87.
   PubMed Web of Science ®Google Scholar
• Chaffer CL, Brueckmann I, Scheel C, Kaestli AJ, Wiggins PA, Rodrigues LO, Normal and neoplastic nonstem cells can spontaneously convert to a stem-like state. Proc Natl Acad Sci USA. 2011;108:7950–5.
   PubMed Web of Science ®Google Scholar
• Quante M, Tu SP, Tomita H, Gonda T, Wang SS, Takashi S, Bone marrow-derived myofibroblasts contribute to the mesenchymal stem cell niche and promote tumor growth. Cancer Cell. 2011;19:257–72.
   PubMed Web of Science ®Google Scholar
• Worthley DL, Ruszkiewicz A, Davies R, Moore S, Nivison-Smith I, Bik To L, Human gastrointestinal neoplasia-associated myofibroblasts can develop from bone marrow-derived cells following allogeneic stem cell transplantation. Stem Cells. 2009;27:1463–8.
   PubMed Web of Science ®Google Scholar
• Sansone P, Storci G, Tavolari S, Guarnieri T, Giovannini C, Taffurelli M, IL-6 triggers malignant features in mammospheres from human ductal breast carcinoma and normal mammary gland. J Clin Invest. 2007;117:3988–4002.
   PubMed Web of Science ®Google Scholar
• Sneddon JB, Zhen HH, Montgomery K, van de Rijn M, Tward AD, West R, Bone morphogenetic protein antagonist gremlin 1 is widely expressed by cancer-associated stromal cells and can promote tumor cell proliferation. Proc Natl Acad Sci USA. 2006;103:14842–7.
   PubMed Web of Science ®Google Scholar
• Rudnick JA, Arendt LM, Klebba I, Hinds JW, Iyer V, Gupta PB, Functional heterogeneity of breast fibroblasts is defined by a prostaglandin secretory phenotype that promotes expansion of cancer-stem like cells. PLoS ONE. 2011;6:e24605.
   Web of Science ®Google Scholar
• Gaggioli C, Hooper S, Hidalgo-Carcedo C, Grosse R, Marshall JF, Harrington K, Fibroblast-led collective invasion of carcinoma cells with differing roles for RhoGTPases in leading and following cells. Nat Cell Biol. 2007;9:1392–400.
   PubMed Web of Science ®Google Scholar
• Scott RW, Hooper S, Crighton D, Li A, Konig I, Munro J, LIM kinases are required for invasive path generation by tumor and tumor-associated stromal cells. J Cell Biol. 2010;191:169–85.
   PubMed Web of Science ®Google Scholar
• Samuel MS, Lopez JI, McGhee EJ, Croft DR, Strachan D, Timpson P, Actomyosin-mediated cellular tension drives increased tissue stiffness and beta-catenin activation to induce epidermal hyperplasia and tumor growth. Cancer Cell. 2011;19:776–91.
   PubMed Web of Science ®Google Scholar
• Kaplan RN, Riba RD, Zacharoulis S, Bramley AH, Vincent L, Costa C, VEGFR1-positive haematopoietic bone marrow progenitors initiate the pre-metastatic niche. Nature. 2005;438:820–7.
   PubMed Web of Science ®Google Scholar
• Denko NC, Fontana LA, Hudson KM, Sutphin PD, Raychaudhuri S, Altman R, Investigating hypoxic tumor physiology through gene expression patterns. Oncogene. 2003;22:5907–14.
   PubMed Web of Science ®Google Scholar
• Kirschmann DA, Seftor EA, Fong SF, Nieva DR, Sullivan CM, Edwards EM, A molecular role for lysyl oxidase in breast cancer invasion. Cancer Res. 2002;62:4478–83.
   PubMed Web of Science ®Google Scholar
• Erler JT, Bennewith KL, Nicolau M, Dornhofer N, Kong C, Le QT, Lysyl oxidase is essential for hypoxia-induced metastasis. Nature. 2006;440:1222–6.
   PubMed Web of Science ®Google Scholar
• Fogelgren B, Polgar N, Szauter KM, Ujfaludi Z, Laczko R, Fong KS, Cellular fibronectin binds to lysyl oxidase with high affinity and is critical for its proteolytic activation. J Biol Chem. 2005;280:24690–7.
   PubMed Web of Science ®Google Scholar
• Erler JT, Bennewith KL, Cox TR, Lang G, Bird D, Koong A, Hypoxia-induced lysyl oxidase is a critical mediator of bone marrow cell recruitment to form the premetastatic niche. Cancer Cell. 2009;15:35–44.
   PubMed Web of Science ®Google Scholar
• Bondareva A, Downey CM, Ayres F, Liu W, Boyd SK, Hallgrimsson B, The lysyl oxidase inhibitor, beta-aminopropionitrile, diminishes the metastatic colonization potential of circulating breast cancer cells. PLoS ONE. 2009;4:e5620.
   PubMed Web of Science ®Google Scholar
• Csiszar K. Lysyl oxidases: a novel multifunctional amine oxidase family. Prog Nucleic Acid Res Mol Biol. 2001;70:1–32.
   PubMed Web of Science ®Google Scholar
• Barry-Hamilton V, Spangler R, Marshall D, McCauley S, Rodriguez HM, Oyasu M, Allosteric inhibition of lysyl oxidase-like-2 impedes the development of a pathologic microenvironment. Nat Med. 2010;16:1009–17.
   PubMed Web of Science ®Google Scholar
• Elkabets M, Gifford AM, Scheel C, Nilsson B, Reinhardt F, Bray MA, Human tumors instigate granulin-expressing hematopoietic cells that promote malignancy by activating stromal fibroblasts in mice. J Clin Invest. 2011;121:784–99.
   PubMed Web of Science ®Google Scholar
• O'Connell JT, Sugimoto H, Cooke VG, Macdonald BA, Mehta AI, Lebleu VS, VEGF-A and Tenascin-C produced by S100A4+ stromal cells are important for metastatic colonization. Proc Natl Acad Sci USA. 2011;108:16002–7.
   PubMed Web of Science ®Google Scholar
• Forsberg K, Valyi-Nagy I, Heldin CH, Herlyn M, Westermark B. Platelet-derived growth factor (PDGF) in oncogenesis: development of a vascular connective tissue stroma in xenotransplanted human melanoma producing PDGF-BB. Proc Natl Acad Sci USA. 1993;90:393–7.
   PubMed Web of Science ®Google Scholar
• Pietras K, Ostman A, Sjoquist M, Buchdunger E, Reed RK, Heldin CH, Inhibition of platelet-derived growth factor receptors reduces interstitial hypertension and increases transcapillary transport in tumors. Cancer Res. 2001;61:2929–34.
   PubMed Web of Science ®Google Scholar
• Pietras K, Rubin K, Sjoblom T, Buchdunger E, Sjoquist M, Heldin CH, Inhibition of PDGF receptor signaling in tumor stroma enhances antitumor effect of chemotherapy. Cancer Res. 2002;62:5476–84.
   PubMed Web of Science ®Google Scholar
• Pietras K, Hanahan D. A multitargeted, metronomic, and maximum-tolerated dose "chemo-switch" regimen is antiangiogenic, producing objective responses and survival benefit in a mouse model of cancer. J Clin Oncol. 2005;23:939–52.
   PubMed Web of Science ®Google Scholar
• Hagglof C, Hammarsten P, Josefsson A, Stattin P, Paulsson J, Bergh A, Stromal PDGFRbeta expression in prostate tumors and non-malignant prostate tissue predicts prostate cancer survival. PLoS ONE. 2010;5:e10747.
   PubMed Web of Science ®Google Scholar
• Paulsson J, Sjoblom T, Micke P, Ponten F, Landberg G, Heldin CH, Prognostic significance of stromal platelet-derived growth factor beta-receptor expression in human breast cancer. Am J Pathol. 2009;175:334–41.
   PubMed Web of Science ®Google Scholar
• Wennmalm K, Ostman A, Bergh J. Stromal signature identifies basal breast cancers. Nat Med. 2009;15:237–8; author reply 8.
   PubMed Web of Science ®Google Scholar
• Navab R, Strumpf D, Bandarchi B, Zhu CQ, Pintilie M, Ramnarine VR, Prognostic gene-expression signature of carcinoma-associated fibroblasts in non-small cell lung cancer. Proc Natl Acad Sci USA. 2011;108:7160–5.
   PubMed Web of Science ®Google Scholar
• Saito RA, Micke P, Paulsson J, Augsten M, Pena C, Jonsson P, Forkhead box F1 regulates tumor-promoting properties of cancer-associated fibroblasts in lung cancer. Cancer Res. 2010;70:2644–54.
   PubMed Web of Science ®Google Scholar
• Duda DG, Duyverman AM, Kohno M, Snuderl M, Steller EJ, Fukumura D, Malignant cells facilitate lung metastasis by bringing their own soil. Proc Natl Acad Sci USA. 2010;107:21677–82.
   PubMed Web of Science ®Google Scholar
• Grum-Schwensen B, Klingelhofer J, Berg CH, El-Naaman C, Grigorian M, Lukanidin E, Suppression of tumor development and metastasis formation in mice lacking the S100A4(mts1) gene. Cancer Res. 2005;65:3772–80.
   PubMed Web of Science ®Google Scholar
• Augsten M, Hagglof C, Olsson E, Stolz C, Tsagozis P, Levchenko T, CXCL14 is an autocrine growth factor for fibroblasts and acts as a multi-modal stimulator of prostate tumor growth. Proc Natl Acad Sci USA. 2009;106:3414–19.
   PubMed Web of Science ®Google Scholar
• Pavlides S, Whitaker-Menezes D, Castello-Cros R, Flomenberg N, Witkiewicz AK, Frank PG, The reverse Warburg effect: aerobic glycolysis in cancer associated fibroblasts and the tumor stroma. Cell Cycle. 2009;8:3984–4001.
   PubMed Web of Science ®Google Scholar
• Koukourakis MI, Giatromanolaki A, Harris AL, Sivridis E. Comparison of metabolic pathways between cancer cells and stromal cells in colorectal carcinomas: a metabolic survival role for tumor-associated stroma. Cancer Res. 2006;66:632–7.
   PubMed Web of Science ®Google Scholar
• Farmer P, Bonnefoi H, Anderle P, Cameron D, Wirapati P, Becette V, A stroma-related gene signature predicts resistance to neoadjuvant chemotherapy in breast cancer. Nat Med. 2009;15:68–74.
   PubMed Web of Science ®Google Scholar
• McMillin DW, Delmore J, Weisberg E, Negri JM, Geer DC, Klippel S, Tumor cell-specific bioluminescence platform to identify stroma-induced changes to anticancer drug activity. Nat Med. 2010;16:483–9.
   PubMed Web of Science ®Google Scholar
• Flaberg E, Markasz L, Petranyi G, Stuber G, Dicso F, Alchihabi N, High-throughput live-cell imaging reveals differential inhibition of tumor cell proliferation by human fibroblasts. Int J Cancer. 2011;15:128:2793–802.
   Google Scholar